Lutetium-177-dotatate Archives - SAM Nordic

Log in

Don't have an account? Create one here

Haukeland first out in Norway to offer Lutetium-177-dotatate

Haukeland universitetssjukehus is the first hospital in Norway to offer the innovative radiopharmaceutical, Lutetium-177-dotatate to patients with neuroendocrine tumours. Previously...

29 October 2019

AAA gains European approval for Lutathera® for GEP-NET – Completes First Theragnostic Radiopharmaceutical Pairing in Oncology

The European Commission has approved the marketing authorization of Lutetium (177Lu) oxodotreotide (Lutathera) for the treatment of unresectable or metastatic,...